Logo image of IRBT

IROBOT CORP (IRBT) Stock Fundamental Analysis

NASDAQ:IRBT - Nasdaq - US4627261005 - Common Stock - Currency: USD

2.44  +0.02 (+0.83%)

After market: 2.44 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IRBT. IRBT was compared to 64 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. IRBT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IRBT had negative earnings in the past year.
IRBT had a negative operating cash flow in the past year.
In multiple years IRBT reported negative net income over the last 5 years.
In the past 5 years IRBT reported 4 times negative operating cash flow.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

The Return On Assets of IRBT (-28.19%) is worse than 90.63% of its industry peers.
IRBT has a worse Return On Equity (-237.62%) than 92.19% of its industry peers.
Industry RankSector Rank
ROA -28.19%
ROE -237.62%
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

IRBT's Gross Margin of 21.64% is on the low side compared to the rest of the industry. IRBT is outperformed by 68.75% of its industry peers.
IRBT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
IRBT has more shares outstanding than it did 1 year ago.
IRBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IRBT is higher compared to a year ago.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IRBT has an Altman-Z score of 0.46. This is a bad value and indicates that IRBT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.46, IRBT is doing worse than 76.56% of the companies in the same industry.
IRBT has a Debt/Equity ratio of 3.28. This is a high value indicating a heavy dependency on external financing.
IRBT has a worse Debt to Equity ratio (3.28) than 95.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.28
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACCN/A
WACC10.72%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

IRBT has a Current Ratio of 1.32. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
IRBT's Current ratio of 1.32 is on the low side compared to the rest of the industry. IRBT is outperformed by 84.38% of its industry peers.
IRBT has a Quick Ratio of 1.32. This is a bad value and indicates that IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.97, IRBT perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.97
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.59% over the past year.
IRBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.44%.
The Revenue for IRBT have been decreasing by -10.90% on average. This is quite bad
EPS 1Y (TTM)28.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.19%
Revenue 1Y (TTM)-23.44%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-44.06%

3.2 Future

IRBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.34% yearly.
Based on estimates for the next years, IRBT will show a quite strong growth in Revenue. The Revenue will grow by 9.89% on average per year.
EPS Next Y65.26%
EPS Next 2Y33.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.01%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as IRBT's earnings are expected to grow with 33.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.34%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IRBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

NASDAQ:IRBT (4/28/2025, 8:17:21 PM)

After market: 2.44 0 (0%)

2.44

+0.02 (+0.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)05-06 2025-05-06
Inst Owners59.66%
Inst Owner Change0.38%
Ins Owners4%
Ins Owner Change15.43%
Market Cap74.74M
Analysts45.71
Price Target11.22 (359.84%)
Short Float %16.68%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)67.49%
Min EPS beat(2)-17.08%
Max EPS beat(2)152.06%
EPS beat(4)2
Avg EPS beat(4)37.96%
Min EPS beat(4)-17.08%
Max EPS beat(4)152.06%
EPS beat(8)4
Avg EPS beat(8)10.44%
EPS beat(12)6
Avg EPS beat(12)-70.67%
EPS beat(16)8
Avg EPS beat(16)-23.91%
Revenue beat(2)0
Avg Revenue beat(2)-9.95%
Min Revenue beat(2)-13.17%
Max Revenue beat(2)-6.73%
Revenue beat(4)1
Avg Revenue beat(4)-5.48%
Min Revenue beat(4)-13.17%
Max Revenue beat(4)1.44%
Revenue beat(8)2
Avg Revenue beat(8)-10.15%
Revenue beat(12)2
Avg Revenue beat(12)-12.23%
Revenue beat(16)5
Avg Revenue beat(16)-8.29%
PT rev (1m)0%
PT rev (3m)-4.1%
EPS NQ rev (1m)-38.04%
EPS NQ rev (3m)-72.79%
EPS NY rev (1m)-22.34%
EPS NY rev (3m)-26.17%
Revenue NQ rev (1m)-4.95%
Revenue NQ rev (3m)-6.72%
Revenue NY rev (1m)-1.94%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 1.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.52
EYN/A
EPS(NY)-1.92
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS22.26
BVpS2
TBVpS-3.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.19%
ROE -237.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.64%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score3
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 3.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.54%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.97
Altman-Z 0.46
F-Score3
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.19%
EPS Next Y65.26%
EPS Next 2Y33.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.44%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-44.06%
Revenue Next Year-2.01%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.06%
OCF growth 3YN/A
OCF growth 5YN/A